TerminatedPhase 3

Influence on Erythropoetin-level by Xenon

Stopped: The analysis of the blood samples was much expensive than calculated. The recruitment had to be stopped after 36 study participants.

Germany36 participantsStarted 2014-05

Plain-language summary

The purpose of this study is to analyze the effect of xenon-inhalation on erythropoetin-level in blood of healthy volunteers and to determine the efficient time of inhalation. Hypothesis: Xenon-inhalation enhances erythropoetin-levels in blood

Who can participate

Age range18 Years – 65 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male subjects * Age: \> 18 years * legally competent to sign * without any known medical condition or medication prescribed at the University Hospital RWTH Aachen, Germany * Persons that are able and willing to understand and follow the instructions of the study personnel * Signed informed consent Exclusion Criteria: * Smoker, alcoholic or person who regularly consumes drugs or medication * Persons with a medical condition that is contraindicated with the planned treatment * Known hypersensitivity against xenon * Persons not legally competent to sign * Simultaneous participation at any other trial * Blood-loss due to trauma during the period of the study or 2 months previous * Blood donation during the period of the study or 2 months previous

What they're measuring

Change from baseline in erythropoetin-level in blood of healthy volunteers up to 216 hrs after the first of three xenon applications in total

Timeframe: up to 216 hrs after first xenon-application

Trial details

NCT IDNCT02129400

SponsorRWTH Aachen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-01

View on ClinicalTrials.gov More Healthy Volunteers trials